834 related articles for article (PubMed ID: 19689234)
21. MCI patients' EEGs show group differences between those who progress and those who do not progress to AD.
Moretti DV; Frisoni GB; Fracassi C; Pievani M; Geroldi C; Binetti G; Rossini PM; Zanetti O
Neurobiol Aging; 2011 Apr; 32(4):563-71. PubMed ID: 20022139
[TBL] [Abstract][Full Text] [Related]
22. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
[TBL] [Abstract][Full Text] [Related]
23. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.
Leung KK; Barnes J; Ridgway GR; Bartlett JW; Clarkson MJ; Macdonald K; Schuff N; Fox NC; Ourselin S;
Neuroimage; 2010 Jul; 51(4):1345-59. PubMed ID: 20230901
[TBL] [Abstract][Full Text] [Related]
24. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
Chetelat G; Baron JC
Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
[TBL] [Abstract][Full Text] [Related]
25. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
[TBL] [Abstract][Full Text] [Related]
26. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.
Devanand DP; Bansal R; Liu J; Hao X; Pradhaban G; Peterson BS
Neuroimage; 2012 Apr; 60(3):1622-9. PubMed ID: 22289801
[TBL] [Abstract][Full Text] [Related]
27. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
[TBL] [Abstract][Full Text] [Related]
28. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
Varon D; Barker W; Loewenstein D; Greig M; Bohorquez A; Santos I; Shen Q; Harper M; Vallejo-Luces T; Duara R;
Int J Geriatr Psychiatry; 2015 Feb; 30(2):192-200. PubMed ID: 24816477
[TBL] [Abstract][Full Text] [Related]
29. Complexity analysis of cortical surface detects changes in future Alzheimer's disease converters.
Ruiz de Miras J; Costumero V; Belloch V; Escudero J; Ávila C; Sepulcre J
Hum Brain Mapp; 2017 Dec; 38(12):5905-5918. PubMed ID: 28856799
[TBL] [Abstract][Full Text] [Related]
30. Comparison of manual and automated determination of hippocampal volumes in MCI and early AD.
Shen L; Saykin AJ; Kim S; Firpi HA; West JD; Risacher SL; McDonald BC; McHugh TL; Wishart HA; Flashman LA
Brain Imaging Behav; 2010 Mar; 4(1):86-95. PubMed ID: 20454594
[TBL] [Abstract][Full Text] [Related]
31. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.
Hua X; Leow AD; Parikshak N; Lee S; Chiang MC; Toga AW; Jack CR; Weiner MW; Thompson PM;
Neuroimage; 2008 Nov; 43(3):458-69. PubMed ID: 18691658
[TBL] [Abstract][Full Text] [Related]
32. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.
Henneman WJ; Sluimer JD; Barnes J; van der Flier WM; Sluimer IC; Fox NC; Scheltens P; Vrenken H; Barkhof F
Neurology; 2009 Mar; 72(11):999-1007. PubMed ID: 19289740
[TBL] [Abstract][Full Text] [Related]
33. Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features.
Li Y; Wang Y; Wu G; Shi F; Zhou L; Lin W; Shen D;
Neurobiol Aging; 2012 Feb; 33(2):427.e15-30. PubMed ID: 21272960
[TBL] [Abstract][Full Text] [Related]
34. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.
deToledo-Morrell L; Stoub TR; Bulgakova M; Wilson RS; Bennett DA; Leurgans S; Wuu J; Turner DA
Neurobiol Aging; 2004 Oct; 25(9):1197-203. PubMed ID: 15312965
[TBL] [Abstract][Full Text] [Related]
35. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.
Hua X; Lee S; Yanovsky I; Leow AD; Chou YY; Ho AJ; Gutman B; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
Neuroimage; 2009 Dec; 48(4):668-81. PubMed ID: 19615450
[TBL] [Abstract][Full Text] [Related]
36. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
[TBL] [Abstract][Full Text] [Related]
37. A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer's disease.
Nestor SM; Gibson E; Gao FQ; Kiss A; Black SE;
Neuroimage; 2013 Feb; 66():50-70. PubMed ID: 23142652
[TBL] [Abstract][Full Text] [Related]
38. Structural MRI biomarkers for preclinical and mild Alzheimer's disease.
Fennema-Notestine C; Hagler DJ; McEvoy LK; Fleisher AS; Wu EH; Karow DS; Dale AM;
Hum Brain Mapp; 2009 Oct; 30(10):3238-53. PubMed ID: 19277975
[TBL] [Abstract][Full Text] [Related]
39. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
Mah L; Binns MA; Steffens DC;
Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
[TBL] [Abstract][Full Text] [Related]
40. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
